Related Experiment Video
Updated: May 26, 2025

Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
Treatment of glaucoma with drug-loaded contact lenses: A systematic review and meta-analysis
Diya Zhang1, Cong Ren2, Xuan Wang1
1Shandong University of Traditional Chinese Medicine, Jinan, 250355, China.
Objective:
This study is a systematical review regarding the glaucoma treatment with drug-loaded contact lenses. The effectiveness and safety about that were summarized, which providing effective suggestions and guidance for clinical research.
Methods:
The studies published up to May 1, 2024 on the treatment of glaucoma with sustained-release contact lenses were searched from CNKI, Wanfang Data, VIP, PubMed, Embase, Cochrane Library, and Medline. CAMARADES was used to evaluate literature quality. The safety, endpoints of intraocular pressure reduction (IOPR) and duration of intraocular pressure (IOP) decline during glaucoma treatment were analyzed by means of qualitative and quantitative methods. The protocol registration number is CRD42024487157.
Results:
47 studies were included. In clinical trials, glaucoma patients showed a 50% reduction in IOP and no corneal tissue destruction after wearing contact lenses. In animal experiments, the endpoint IOPR [MD = 0.58, 95%CI (0.37, 0.80), P < 0.00001] of the medicated contact lenses group was significantly better than that of the eye drops group. Subgroup analysis showed that contact lenses loaded with timolol (TML), with TML + dorzolamide, and with TML + latanoprost, which compared to eye drops, had a better effect on reducing IOP, while contact lenses loaded with puerarin, latanoprost, and TML + bimatoprost showed no statistical difference. Most studies demonstrated the duration of IOP reduction and drugs release in vitro for ≥3 days during contact lenses treatment.
Conclusion:
Most drug-loaded contact lenses exhibit excellent effectiveness and safety. The nanoparticle-loaded contact lenses containing TML for glaucoma treatment is recommended in future clinical research.
Insights
Drug-loaded contact lenses offer effective and safe glaucoma treatment, significantly reducing intraocular pressure (IOP) compared to eye drops. Nanoparticle formulations with timolol are recommended for future clinical research.
Area of Science:
- Ophthalmology
- Materials Science
- Pharmacology
Background:
- Glaucoma treatment traditionally relies on eye drops, which can have compliance issues and side effects.
- Drug-loaded contact lenses offer a novel sustained-release drug delivery system for managing intraocular pressure (IOP).
Purpose of the Study:
- To systematically review the effectiveness and safety of drug-loaded contact lenses for glaucoma treatment.
- To provide guidance for future clinical research in this area.
Main Methods:
- A systematic literature search was conducted up to May 1, 2024, across multiple databases.
- Included studies were assessed for quality using CAMARADES.
- Safety, intraocular pressure reduction (IOPR), and duration of IOP decline were analyzed qualitatively and quantitatively.
Main Results:
- 47 studies were included, showing significant IOP reduction (up to 50%) and no corneal damage in clinical trials.
- Medicated contact lenses demonstrated superior IOP reduction compared to eye drops in animal models.
- Contact lenses with timolol, timolol + dorzolamide, and timolol + latanoprost showed better IOP reduction; puerarin, latanoprost, and timolol + bimatoprost did not.
- Sustained drug release and IOP reduction for at least 3 days were observed.
Conclusions:
- Drug-loaded contact lenses demonstrate excellent efficacy and safety for glaucoma management.
- Nanoparticle-loaded contact lenses containing timolol are a promising option for future clinical investigation.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

